Redsense presents at Stora Aktiedagarna Stockholm

Stora Aktiedagarna is a highly intensive three-day event organized by Aktiespararna in Stockholm March 13-15, 2023. The event will be held at Birger Jarl Konferens and is free of charge if you register. Participants will be able to take part in around 60 company presentations over the three days.

Redsense CEO Pontus Nobréus will present the company on Tuesday March 14 and answer your questions. The presentation will be held in Swedish.

To register, for the complete program and more information about the event see:  www.aktiespararna.se/aktiviteter/stora-aktiedagarna-i-stockholm-i-mars

Contact information

For more information, please contact: 
Pontus Nobréus, CEO
Telephone: +46 72-171 1264
E-mail: pontus.nobreus (at) redsensemedical.com

Redsense Medical AB (publ), 556646-4862

ABOUT REDSENSE MEDICAL

Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.